Mésothéliome (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mésothéliome" in French language version.

refsWebsite

Global rank French rank

8wikipedia.org

low place

3nih.gov

4^th place

12^th place

3nejm.org

2,374^th place

298^th place

3sciencedirect.com

149^th place

80^th place

3ascopubs.org

low place

7,741^st place

2sante.fr

8,603^rd place

517^th place

2nature.com

234^th place

147^th place

2lww.com

2,769^th place

931^st place

2thelancet.com

2,393^rd place

506^th place

1doi.org

2^nd place

3^rd place

1anses.fr

low place

740^th place

1bmj.com

1,226^th place

347^th place

1ersjournals.com

low place

7,855^th place

1springer.com

274^th place

223^rd place

1amegroups.com

low place

1danger-sante.org

low place

1batiactu.com

low place

718^th place

1mdpi.com

2,912^th place

1,010^th place

1alternatives-economiques.fr

low place

1,084^th place

1journaldelenvironnement.net

low place

2,853^rd place

1jamanetwork.com

2,650^th place

689^th place

alternatives-economiques.fr

Igor Martinache, « Intoxications élémentaires », Alternatives économiques,‎ 8 novembre 2017 (lire en ligne, consulté le 31 janvier 2022).

amegroups.com

jovs.amegroups.com

Wald O, Groth SS, Burt BM, Sugarbaker DJ, Role of thoracoscopy, mediastinoscopy and laparoscopy in the diagnosis and staging of malignant pleural mesothelioma, J Vis Surg, 2016;2:129-129

anses.fr

Camille Larue et Marie Carrière, Les nanoparticules dans l’écosystème sol[PDF], février 2010 à août 2010, CEA/ADEME, IRAMIS/SIS2M/LSDRM, Gif-sur-Yvette (voir le chapitre intitulé Phénomènes précoces dans la cancérogenèse du mésothéliome).

ascopubs.org

jco.ascopubs.org

(en) Hollevoet K, Reitsma JB, Creaney J et al. Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis, J Clin Oncol, 2012;30:1541-1549.
(en) Vogelzang NJ, Rusthoven JJ, Symanowski J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma, J Clin Oncol, 2003;21:2636-2644.
(en) van Meerbeeck JP, Gaafar R, Manegold C et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada, J Clin Oncol, 2005;23:6881-6889.

batiactu.com

BatiActu et AFP (2014), brève intitulée L'amiante, un fléau qui pourrait causer 100.000 morts d'ici à 2050, avec AFP (22 août 2014, (consulté le 25 août 2014).

bmj.com

thorax.bmj.com

Woolhouse I, Bishop L, Darlison L et al. British Thoracic Society guideline for the investigation and management of malignant pleural mesothelioma, Thorax, 2018;73:Suppl 1:i1-i30

danger-sante.org

Le cancer inconnu du grand public : Mésothéliome (mesothelioma).

doi.org

dx.doi.org

(en) Domestic Asbestos Exposure: A Review of Epidemiologic and Exposure Data Goswami E1, Craven V, Dahlstrom DL, Alexander D, Mowat F. Int J Environ Res Public Health. 2013 Oct 31;10(11):5629-70. DOI 10.3390/ijerph10115629. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863863/

ersjournals.com

err.ersjournals.com

Bibby AC, Tsim S, Kanellakis N, et al. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment, Eur Respir Rev, 2016;25:472-486

jamanetwork.com

Davies HE, Mishra EK, Kahan BC et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial, JAMA 2012;307:2383-2389

journaldelenvironnement.net

Sabine Casalonga Mésothéliomes : la déclaration obligatoire a débuté, Journal de l'environnement, 25 janvier 2011.

lww.com

journals.lww.com

(en) Flores RM, Zakowski M, Venkatraman E et al. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center, J Thorac Oncol (en), 2007;2:957-965.
(en) Santoro A, O'Brien ME, Stahel RA et al. Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaive patients with malignant pleural mesothelioma: results of the International Expanded Access Program, J Thorac Oncol (en), 2008;3:756-763.

mdpi.com

Panou V, Røe OD, Inherited genetic mutations and polymorphisms in malignant mesothelioma: a comprehensive review, Int J Mol Sci, 2020;21:4327-4327

nature.com

Blum Y, Meiller C, Quetel L et al. Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications, Nat Commun, 2019;10:1333-1333
Testa JR, Cheung M, Pei J et al. Germline BAP1 mutations predispose to malignant mesothelioma, Nat Genet, 2011;43:1022-1025

nejm.org

Janes SM, Alrifai D, Fennell DA, Perspectives on the treatment of malignant pleural mesothelioma, N Engl J Med, 2021;385:1207-1218
(en) Pass HI, Lott D, Lonardo F et al. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels, N Engl J Med, 2005;353:1564-1573.
(en) Pass HI, Levin SM, Harbut MR et al. Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma, N Engl J Med, 2012;367:1417-1427.

nih.gov

ncbi.nlm.nih.gov

(en) Asbestos and peritoneal mesothelioma among college-educated men. Welch LS1, Acherman YI, Haile E, Sokas RK, Sugarbaker PH. Int J Occup Environ Health (en). 2005 Jul-Sep;11(3):254-8. https://www.ncbi.nlm.nih.gov/pubmed/16130966
(en) Domestic Asbestos Exposure: A Review of Epidemiologic and Exposure Data Goswami E1, Craven V, Dahlstrom DL, Alexander D, Mowat F. Int J Environ Res Public Health. 2013 Oct 31;10(11):5629-70. DOI 10.3390/ijerph10115629. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863863/
(en)"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province", J. C. Wagner, C. A. Sleggs et P. Marchand in Br J Ind Med. (1960) volume 17, pages 260-271 PubMed 13782506.

sante.fr

invs.sante.fr

Le mésothéliome devient la 31^e maladie à déclaration obligatoire (MDO) en France, communiqué de presse du 18 janvier 2012 de l'Institut de veille sanitaire.
Communiqué InVS, Déclaration obligatoire des mésothéliomes : démarrage le 1^er janvier 2011 de la phase pilote dans six régions ; janvier 2011.

sciencedirect.com

Rusch VW, Chansky K, Kindler HL et al. The IASLC Mesothelioma Staging Project: proposals for the M descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for mesothelioma, J Thorac Oncol, 2016;11:2112-2119
Baas P, Scherpereel A, Nowak AK et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial, Lancet, 2021;397:375-386
Stahel RA, Riesterer O, Xyrafas A et al. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial, Lancet Oncol, 2015;16:1651-1658

springer.com

link.springer.com

Basu S, Saboury B, Torigian DA, Alavi A, Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment, Mol Imaging Biol, 2011;13:801-811

thelancet.com

(en) Zalcman, « Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial », The Lancet,‎ 21 décembre 2015 (lire en ligne).
Chu Q, Perrone F, Greillier L et al. Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial, Lancet; 2023;402:2295-2306

wikipedia.org

en.wikipedia.org

(en) Asbestos and peritoneal mesothelioma among college-educated men. Welch LS1, Acherman YI, Haile E, Sokas RK, Sugarbaker PH. Int J Occup Environ Health (en). 2005 Jul-Sep;11(3):254-8. https://www.ncbi.nlm.nih.gov/pubmed/16130966
(en) Nature Reviews Cancer, vol. 7, 2, p. 147-154 (2007), Welch LS, Acherman YI, Haile E, Sokas RK, Sugarbaker PH. Asbestos and peritoneal mesothelioma among college-educated men. Int J Occup Environ Health (en) 2005; 11:254-8.
(en) Flores RM, Zakowski M, Venkatraman E et al. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center, J Thorac Oncol (en), 2007;2:957-965.
(en) Santoro A, O'Brien ME, Stahel RA et al. Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaive patients with malignant pleural mesothelioma: results of the International Expanded Access Program, J Thorac Oncol (en), 2008;3:756-763.
(en) Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol (en) 2006.
(en) Welch LS, Acherman YI, Haile E, Sokas RK, Sugarbaker PH. Asbestos and peritoneal mesothelioma among college-educated men. Int J Occup Environ Health (en) 2005; 11:254-8.
(en) Roushdy-Hammady I. Contested etiology: cancer risk among two Anatolian populations in Turkey and Europe. Cult Med Psychiatry (en) 2004; 28:315-39.

de.wikipedia.org

(en) Sugarbaker PH, Yan TD, Stuart OA, Yoo D. Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol (de) 2006; 32:686-91.